UBS Cuts Estimates and Price Target on Texas Instruments (TXN); Demand Concerns
Get Alerts TXN Hot Sheet
Price: $175.25 +0.25%
Rating Summary:
18 Buy, 23 Hold, 6 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
18 Buy, 23 Hold, 6 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
UBS maintains a 'Neutral' on Texas Instruments (NASDAQ: TXN) price target of $30.00 (from $35.00).
Analyst, Uche Orji, said, "TXN tightened its outlook for 2Q to Rev/EPS of $3.28-3.42B/32-36c, vs. prior of $3.22–3.48B/30-38c. The company indicated that the orders are trending in line with expectations and inventory in the channel remains low at 6.5 weeks as distributors and OEMs are hesitant to restock inventories. Despite TI’s commentary of stable end-market trends, we remain concerned about end-demand, as leading indicators such as PMI from US, China and Euro Zone point to a weakening demand environment."
UBS lowers FY12 EPS estimate from $1.82 to $1.77 and FY13 from $2.19 to $2.05.
For an analyst ratings summary and ratings history on Texas Instruments click here. For more ratings news on Texas Instruments click here.
Shares of Texas Instruments closed at $27.65 yesterday.
Analyst, Uche Orji, said, "TXN tightened its outlook for 2Q to Rev/EPS of $3.28-3.42B/32-36c, vs. prior of $3.22–3.48B/30-38c. The company indicated that the orders are trending in line with expectations and inventory in the channel remains low at 6.5 weeks as distributors and OEMs are hesitant to restock inventories. Despite TI’s commentary of stable end-market trends, we remain concerned about end-demand, as leading indicators such as PMI from US, China and Euro Zone point to a weakening demand environment."
UBS lowers FY12 EPS estimate from $1.82 to $1.77 and FY13 from $2.19 to $2.05.
For an analyst ratings summary and ratings history on Texas Instruments click here. For more ratings news on Texas Instruments click here.
Shares of Texas Instruments closed at $27.65 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amazon.com (AMZN) PT Raised to $215 at UBS
- Parade Technologies Ltd. (4966:TT) PT Lowered to NT$800 at JPMorgan
- Sage Therapeutics (SAGE) PT Lowered to $18 at Truist Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!